News

Dr. Said Ibrahim, a leading physician-scientist whose research focuses on healthcare disparities, has been named the inaugural chief of the newly established Division of Healthcare Delivery Science and Innovation in the Department of Healthcare Policy and Research at Weill Cornell Medicine, effective Feb. 1.

Delirium is a frequent occurrence among children hospitalized with cancer, affecting nearly one in five patients.

Dr. Jessica Tyler has been elected a fellow of the American Association for the Advancement of Science. 

Weill Cornell Medicine researchers have received a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to conduct an in-depth study of the mechanisms that cause scar tissue to form in the lung and kidney.

A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to a finding by Weill Cornell Medicine researchers.

Cornell scientists are working to improve radiation therapy.

Antibiotic treatment for Tuberculosis dramatically reduces quantities of several bacteria associated with immune system functions for at least a year, according to a study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Dr. Catherine Lord, director of the Center for Autism and the Developing Brain, a collaboration between Weill Cornell Medicine, NewYork-Presbyterian, and Columbia University College of Physicians and Surgeons, received the prestigious Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine.

Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases, sparking hope for the development of new treatment and therapies for the conditions.

Using techniques pioneered at Weill Cornell Medicine, scientists have captured the first video recordings of a key protein whose function is essential to a deadly foodborne bacteria.

Newer, non-chemotherapy drugs benefit many patients with mantle cell lymphoma, an incurable form of blood cancer, and deserve deeper study in clinical trials, according to an editorial published Sept. 12 in Blood by scientists at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Anthony Hollenberg, a leading physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.

In spring 2013, Manhattan resident Jeri Bloome was 92 years old but had the energy of someone decades younger. She peppered her schedule with tugboat rides on the East River, strolls along the Brighton Beach boardwalk, lunches in Chinatown and visits to the Metropolitan Museum of Art with her husband of more than half a century.

Dr. Daniel Fitzgerald, an international leader in infectious diseases, has been named director of the Center for Global Health at Weill Cornell Medicine.

Transplanting young blood vessel cells into older mice can make their aged stem cells take on the characteristics of young stem cells, leading to healthier blood systems and promoting better recovery from cancer treatment side effects, according to new research from Weill Cornell Medicine.

Women diagnosed with an infectious parasitic disease prevalent in sub-Saharan Africa are at increased risk of contracting human immunodeficiency virus (HIV), and both men and women who had this parasitic disease developed higher HIV viral loads after becoming HIV-infected, according to a study from Weill Cornell Medicine investigators.

A new therapy that uses blood-vessel-lining cells to regenerate damaged tissue has the potential to treat liver cirrhosis, Weill Cornell Medicine scientists demonstrate in new research.

In an age of overabundant and accessible information, when evidence-based research is devalued, how can scientists and journalists work in concert to rightfully inform the public of medical progress?

The goal of the Dean’s Inaugural Symposium on Opportunities for Entrepreneurship and Academic Drug Development, hosted at Weill Cornell Medicine’s Uris Auditorium, was to highlight the resources available to investigators to help them turn their research findings into new treatments and therapies for patients.

When Dr. Onyinye Balogun was a young girl, her father’s only sister was diagnosed with breast cancer back home in their native Nigeria. Dr. Balogun had recently immigrated to the United States with her parents, but on a return visit the severity of her aunt’s disease became clear.